Eberhard Draeger

Lower Within-Subject Variability of Insulin Detemir in Comparison to NPH Insulin and Insulin Glargine in People With Type 1 Diabetes

Tim Heise, Leszek Nosek, Birgitte Rønn et al. · Diabetes · 2004 · 619 citations · Full text

Medicine, Endocrinology, Pharmacokinetics +17

Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin Aspart

P Vague, Jean-Louis Sélam, Svein Skeie et al. · Diabetes Care · 2003 · 294 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Lower within‐subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes

T Haak, Antonio Tiengo, Eberhard Draeger et al. · Diabetes Obesity and Metabolism · 2004 · 280 citations

Medicine, Endocrinology, Pharmacotherapy +17

A Double-Blind, Randomized, Dose-Response Study Investigating the Pharmacodynamic and Pharmacokinetic Properties of the Long-Acting Insulin Analog Detemir

Johannes Plank, Manfred Bodenlenz, Frank Sinner et al. · Diabetes Care · 2005 · 272 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Insulin Detemir Offers Improved Glycemic Control Compared With NPH Insulin in People With Type 1 Diabetes

Philip Home, Paul B. Bartley, David Russell‐Jones et al. · Diabetes Care · 2004 · 257 citations · Full text

Medicine, Endocrinology, Internal Medicine +17